This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Risky Interaction

Eve J. Higginbotham, MD

Arch Ophthalmol. 1996;114(6):745-746.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS OPHTHALMOLOGISTS we are well aware of the potential side effects of the antiglaucoma medications that we prescribe for our patients. Congestive heart failure or bronchospasm can develop in susceptible patients who are administered topical noncardioselective β-blockers.¹ Excessive doses of adrenergic agonists can result in systemic hypertension or dysrhythmias; fatigue has been reported following the administration of -2 agonists.² Even cholinergic agents, particularly cholinesterase inhibitors, can result in side effects that are related to the gastrointestinal, cardiovascular, pulmonary, and central nervous systems.¹ Finally, it remains to be seen what list of side effects besides bitter taste will be related to the recently introduced topical carbonic anhydrase inhibitor, dorzolamide hydrochloride. Topical administration of medications can result in significant levels in the bloodstream, and, in fact, this route of administration is more similar to intravenous absorption than oral ingestion. However, equally important to the side effects of these medications . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?